Skip to main content
. 2015 Jul 20;24(5):276–282. doi: 10.3109/09638237.2015.1019048

Table 1. Demographic and clinical characteristics of study participants.

  Schizophrenia Controls
Age (Mean ± SD)b 45.1 ± 12.3 51.7 ± 8.8
Genderc 58% male 75% male
Medication All medicateda N/A
Length of disease  (years) 6.4 ± 3.4 N/A
Symptoms All in relative symptomatic remission No history of mental disorders

aSchizophrenia patients were prescribed anti-psychotic medication, including Olanzapine, Risperidone, Aripiprazole, Perphenazine, Fluphenazine, Ziprasidone, Haloperidol and Quetiapine.

bDifference between age distributions of schizophrenia and control groups is not significant (p = 0.09) using a two-sided Student t-test at a 95% confidence interval.

cDifference between gender distributions of schizophrenia and control groups is not significant (p = 0.31) using Fisher’s exact test.